Notes Payable	9 Months Ended
Sep. 30, 2017
Notes
Notes Payable	1. Notes Payable Notes Payable to Related Parties: The Company owed $2,939,887 and $2,066,165 in notes and accrued interest to an officer and director at September 30, 2017 and December 31, 2016, respectively. During the nine months ended September 30, 2017 and 2016, the Company made no repayments of related party notes or accrued interest. Notes Payable, others: The Company has notes due to unrelated parties totaling $318,192 and $0 at September 30, 2017 and December 31, 2016, respectively. As part of the acquisition of Omni, the Company acquired a note due to a former shareholder of Omni in the amount of $845,000. As of September 30, 2017, the Company had converted approximately $298,000 of the note into common stock. At September 30, 2017 and December 31, 2016, the Company has accrued interest of $52,308 and $0, respectively.

Notes Payable

9 Months Ended

Sep. 30, 2017

1. Notes Payable

Notes Payable to Related Parties:

The Company owed $2,939,887 and $2,066,165 in notes and accrued interest to an officer and director at September 30, 2017 and December 31, 2016, respectively.

During the nine months ended September 30, 2017 and 2016, the Company made no repayments of related party notes or accrued interest.

Notes Payable, others:

The Company has notes due to unrelated parties totaling $318,192 and $0 at September 30, 2017 and December 31, 2016, respectively.

As part of the acquisition of Omni, the Company acquired a note due to a former shareholder of Omni in the amount of $845,000. As of September 30, 2017, the Company had converted approximately $298,000 of the note into common stock.

At September 30, 2017 and December 31, 2016, the Company has accrued interest of $52,308 and $0, respectively.

EASTGATE BIOTECH CORP 10-Q